Mirum Pharmaceuticals and GC Pharma Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat for Rare Liver Diseases in South Korea
- GC Pharma to lead development and commercialization in South Korea - Mirum seeks to…
- GC Pharma to lead development and commercialization in South Korea - Mirum seeks to…
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
Continuing its positive upward momentum TEMPE, Ariz.--(BUSINESS WIRE)--#broadband--PCT International has received Court approval for $5…
Announces first exit from Fund 1, with Sentropy Technologies to merge with Discord SYDNEY &…
HANGZHOU, China--(BUSINESS WIRE)--MOGU Inc. (NYSE: MOGU) (“MOGU” or the “Company”), a leading KOL-driven online fashion…
HOUSTON--(BUSINESS WIRE)--ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-fibrotic…
BROOKLYN HEIGHTS, Ohio--(BUSINESS WIRE)--GrafTech International Ltd. (NYSE:EAF), a leading manufacturer of high-quality graphite electrode products…
WALTHAM, Mass.--(BUSINESS WIRE)--Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and…
MONTREAL--(BUSINESS WIRE)--Rio Tinto has begun reducing production at its BC Works aluminium smelter in Kitimat,…
Highest active safety among electric vehicles in China GUANGZHOU, China--(BUSINESS WIRE)--The XPeng P7 achieved 5-star…